These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35994024)

  • 21. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau strains shape disease.
    Vaquer-Alicea J; Diamond MI; Joachimiak LA
    Acta Neuropathol; 2021 Jul; 142(1):57-71. PubMed ID: 33830330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
    Annadurai N; De Sanctis JB; Hajdúch M; Das V
    Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Structure Biology of Tau and Clue for Aggregation Inhibitor Design.
    Wang D; Huang X; Yan L; Zhou L; Yan C; Wu J; Su Z; Huang Y
    Protein J; 2021 Oct; 40(5):656-668. PubMed ID: 34401998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fungally Derived Isoquinoline Demonstrates Inducer-Specific Tau Aggregation Inhibition.
    Ingham DJ; Blankenfeld BR; Chacko S; Perera C; Oakley BR; Gamblin TC
    Biochemistry; 2021 Jun; 60(21):1658-1669. PubMed ID: 34009955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. To target Tau pathologies, we must embrace and reconstruct their complexities.
    Limorenko G; Lashuel HA
    Neurobiol Dis; 2021 Dec; 161():105536. PubMed ID: 34718129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
    Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
    Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invited review: Prion-like transmission and spreading of tau pathology.
    Clavaguera F; Hench J; Goedert M; Tolnay M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):47-58. PubMed ID: 25399729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.
    Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N
    Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation.
    Zhong H; Liu H; Liu H
    Curr Med Chem; 2024; 31(20):2855-2871. PubMed ID: 37031392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is tau ready for admission to the prion club?
    Hall GF; Patuto BA
    Prion; 2012 Jul; 6(3):223-33. PubMed ID: 22561167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of NFT: Biochemical Approach.
    Hasegawa M
    Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior.
    Giustiniani J; Guillemeau K; Dounane O; Sardin E; Huvent I; Schmitt A; Hamdane M; Buée L; Landrieu I; Lippens G; Baulieu EE; Chambraud B
    FASEB J; 2015 Aug; 29(8):3171-81. PubMed ID: 25888602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propagation of Tau Aggregates and Neurodegeneration.
    Goedert M; Eisenberg DS; Crowther RA
    Annu Rev Neurosci; 2017 Jul; 40():189-210. PubMed ID: 28772101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target.
    Holmes BB; Diamond MI
    J Biol Chem; 2014 Jul; 289(29):19855-61. PubMed ID: 24860099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Prion-Like Behavior of Assembled Tau in Transgenic Mice.
    Clavaguera F; Tolnay M; Goedert M
    Cold Spring Harb Perspect Med; 2017 Oct; 7(10):. PubMed ID: 27940600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryo-EM structures of tau filaments.
    Scheres SH; Zhang W; Falcon B; Goedert M
    Curr Opin Struct Biol; 2020 Oct; 64():17-25. PubMed ID: 32603876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies.
    Ferreira A; Bigio EH
    Mol Med; 2011; 17(7-8):676-85. PubMed ID: 21442128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformation-based assay of tau protein aggregation.
    Fichou Y; Eschmann NA; Keller TJ; Han S
    Methods Cell Biol; 2017; 141():89-112. PubMed ID: 28882313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.